You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: penicillin g sodium


✉ Email this page to a colleague

« Back to Dashboard


penicillin g sodium

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sandoz PENICILLIN G SODIUM penicillin g sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065068 ANDA Sandoz Inc 0781-6153-95 10 VIAL in 1 CARTON (0781-6153-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-6153-94) 2001-02-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Penicillin G Sodium

Last updated: July 28, 2025

Introduction

Penicillin G sodium, also known as benzylpenicillin sodium, remains a cornerstone in the treatment of various bacterial infections. As a primary beta-lactam antibiotic, its production involves complex biotechnological and chemical processes, making reliable and high-quality suppliers critical for pharmaceutical companies, healthcare providers, and global markets. This report provides a comprehensive review of key suppliers for Penicillin G sodium, emphasizing manufacturing capacity, compliance standards, geographic distribution, and market dynamics.


Overview of Penicillin G Sodium

Penicillin G sodium is an injectable form of penicillin that exhibits broad-spectrum bactericidal activity against Gram-positive bacteria. It is typically produced via fermentation of Penicillium chrysogenum strains, followed by purification and formulation. The global demand for Penicillin G sodium remains steady due to its efficacy, especially in hospital settings and for severe infections.

According to the World Health Organization (WHO), the production and supply of penicillin derivatives are subject to stringent quality controls, regulatory approval, and manufacturing standards (such as Good Manufacturing Practice - GMP). The suppliers competition is characterized by established pharmaceutical giants and specialty chemical manufacturers.


Major Suppliers of Penicillin G Sodium

1. Pfizer Inc.

Overview: Pfizer has historically been a dominant player in the antibiotic market, including Penicillin G sodium. The company's manufacturing facilities, primarily located in North America and Europe, meet rigorous quality standards and regulatory compliance.

Capabilities: Pfizer's production of Penicillin G sodium caters to global markets, with substantial capacity supported by modern fermentation and purification processes.

Market Position: Pfizer’s extensive distribution network and established reputation make it a primary supplier for hospitals and pharmaceutical firms worldwide.

2. Novartis AG

Overview: Novartis produces Penicillin G sodium through its pharmaceutical division, leveraging extensive fermentation technology and quality control systems.

Capabilities: Their manufacturing units adhere to international standards, ensuring high-quality output consistent with regulatory requirements like EMA and FDA approvals.

Market Reach: Novartis supplies Penicillin G sodium predominantly across Europe and Asia, maintaining stable supply chains.

3. Teva Pharmaceutical Industries Ltd.

Overview: As a leading generic drug manufacturer, Teva offers Penicillin G sodium with significant manufacturing capacity to serve both local and international markets.

Capabilities: Emphasizing cost-efficiency, Teva's fermentation processes maintain high standards of purity and potency.

Distribution: Their extensive global distribution network ensures widespread availability, particularly in emerging markets.

4. Sandoz (Novartis division)

Overview: Sandoz specializes in generic pharmaceuticals, including Penicillin G sodium, with manufacturing facilities across Europe and Asia.

Capabilities: Sandoz emphasizes affordable, high-quality antibiotics, supported by GMP-compliant production streams.

Market Focus: Sandoz supplies to hospitals and clinics worldwide, especially targeting price-sensitive regions.

5. Apotex Inc.

Overview: Canadian-based Apotex produces Penicillin G sodium primarily for North American markets, emphasizing high purity and compliance.

Capabilities: Their manufacturing processes conform to cGMP standards, with a focus on reliable supply.

Market Position: As a key regional player, Apotex supports both generic and branded formulations.

6. Local and Regional Manufacturers

Numerous smaller manufacturers, particularly in India, China, and Eastern Europe, produce Penicillin G sodium under GMP and other quality standards.

Examples:

  • Shandong Chenyang Pharmaceutical Co., Ltd. (China)
  • Indian Pharmaceutical Alliance (India)

These manufacturers often serve local markets or act as contract manufacturing organizations (CMOs) for larger companies.


Supply Chain and Regulatory Considerations

The supply landscape of Penicillin G sodium is influenced heavily by regulatory approvals, patent status (though many formulations are generics), and manufacturing compliance. The compliance with the International Council for Harmonisation (ICH), FDA regulations, EMA standards, and WHO prequalification impacts market access.

Risks in Supply Chain:

  • Quality non-compliance
  • Manufacturing disruptions due to raw material shortages
  • Regulatory challenges
  • Political or trade restrictions affecting regional manufacturing hubs

Reliability of suppliers hinges upon adherence to GMP, consistent quality, and established distribution channels.


Market Dynamics and Future Outlook

Despite the advent of newer antibiotics, Penicillin G sodium retains relevance due to its efficacy and low cost. The market is expected to remain stable, with growth driven by:

  • Increasing antibiotic resistance requiring effective first-line treatments
  • Expansion into emerging markets with growing healthcare infrastructure
  • Sustained demand in hospital settings for injectable antibiotics

The increasing emphasis on quality assurance and regulatory compliance encourages established suppliers to invest in capacity expansion and quality systems, safeguarding market stability.

Additionally, manufacturers investing in biosynthetic and fermentation innovations could enhance yields, reduce costs, and improve the diversity of supply options, thereby influencing competitive dynamics.


Conclusion

The supply of Penicillin G sodium is characterized by a mixture of established multinational pharmaceutical companies, regional manufacturers, and emerging players. Pfizer, Novartis, and Teva lead in manufacturing capacity and global distribution reach. Regional manufacturers from Asia and Eastern Europe play a vital role in fulfilling local demand.

Reliable sourcing requires careful evaluation of supplier compliance, capacity, and regulatory standing. As antibiotic resistance and treatment protocols evolve, the pharmaceutical industry must prioritize supply security and quality assurance to ensure continuous access to this critical antibiotic.


Key Takeaways

  • Major global suppliers include Pfizer, Novartis, and Teva, complemented by regional manufacturers.
  • Quality standards and regulatory compliance are paramount, with GMP adherence being a baseline requirement.
  • Supply chain stability depends on raw material availability, manufacturing capacity, and regulatory approvals.
  • Penicillin G sodium remains a vital antibiotic, with steady demand driven by healthcare needs and emerging resistance issues.
  • Collaboration with trusted suppliers and ongoing due diligence are essential for uninterrupted supply.

FAQs

Q1: What are the main manufacturing processes for Penicillin G sodium?
A1: Penicillin G sodium is produced through a fermentation process of Penicillium chrysogenum strains, followed by extraction, purification, and chemical stabilization in sodium salt form.

Q2: How do I verify the quality of Penicillin G sodium from different suppliers?
A2: Verify supplier compliance through GMP certificates, regulatory approvals (FDA, EMA), batch testing reports, and independent quality audits.

Q3: Are there regional suppliers specializing in Penicillin G sodium?
A3: Yes, regional suppliers in Asia, especially China and India, play a significant role in local markets due to cost advantages and manufacturing capacity.

Q4: How does antibiotic resistance influence Penicillin G sodium supply?
A4: Increased resistance to penicillin may reduce demand in certain applications but sustains its importance in initial treatment protocols, influencing supply stability.

Q5: What future trends could impact Penicillin G sodium suppliers?
A5: Innovations in biosynthesis, stricter regulatory standards, and global efforts to combat antibiotic resistance will shape supplier competitiveness and quality standards.


References

  1. World Health Organization. (2021). WHO Model List of Essential Medicines, 21st List.
  2. Pfizer Inc. Corporate Report. (2022). Global Antibiotic Portfolio.
  3. Novartis AG. Annual Report. (2022). Antibiotic Manufacturing Capabilities.
  4. Teva Pharmaceutical Industries Ltd..Product Portfolio. (2022).
  5. Sandoz. (2022). Generic Antibiotics Production and Supply Chain.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.